Mixed-protocol, same-syringe combination of gonadotropins: Compatibility of new, highly purified, human-derived FSH (Bravelle™) and hMG (Repronex®)

Today's Therapeutic Trends

Volumn 19, Issue 4, 2001, Pages 213-224

  Marshall, D C ^a   Raike, E ^a   De Silva, M ^a   Nardi, R V ^a  

^a Ferring Pharmaceuticals Inc   (United States)

Author keywords

Bioactivity; Bravelle; Menotropins; Mixed preparation; Reconstitution; Repronex; Same syringe; Urofollitropin

Indexed keywords

FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; UROFOLLITROPIN;

ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG FORMULATION; DRUG MIXTURE; DRUG POTENCY; DRUG STABILITY; FEMALE; MALE; NONHUMAN; RAT; SYRINGE;

EID: 0035178433     PISSN: 07412320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gonadotropins of the swine pituitary: Various biological effects of purified thylakentrin (FSH) and pure metakentrin (ICSH)
2. Clinical effects of human pituitary follicle stimulating hormone
3. Human menopausal gonadotropins
4. Purification and separation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from human postmenopausal gonadotropin (HMG). II. Preparation of biological apparently pure FSH by selective binding of the LH with an anti-HCG serum and subsequent chromatography
5. Pharmakotenics of natural/recombinant FSH (follitropin) and some analogs
6. In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP
7. Potential clinical applications of recombinant FSH
8. A double-blind, randomized, dose finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon®)
9. Effects of luteinizing hormone activity on ovulation induction outcome
10. Ovulation induction using purified follicle-stimulating hormone
11. Stability, potency, and preservative effectiveness of epoetin alfa after addition of a bacteriostatic diluent
12. Adsorption of calcitonin to glass
13. Surface denaturation of proteins: The thermal inactivation of β-galactosidase (Escbericbia coli) on wall-liquid surfaces
14. A biological, immunological and physico-chemical comparison of the current clinical batches of the recombinant FSH preparations Gonal-F and Puregon
15. Stability and stabilization of globular proteins in solution
16. Biological activity of recombinant interleukin-2 in intravenous admixtures containing antibiotic, morphine sulfate, or total parenteral nutrient solution
17. Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock copolymers